Geographic & priority populations

Third COVID-19 vaccine dose during pregnancy does not pose any significant risk to pregnant individuals or their newborns

A CITF-funded study, published in BMJ Medicine, reported that pregnant individuals who received a third COVID-19 vaccine dose (first booster dose) during pregnancy had no increased risk of adverse pregnancy, fetal, and neonatal outcomes compared to those who did not receive a third dose. This study was led by Dr. Deshayne Fell (University of Ottawa and CHEO Research Institute).

2023-07-31T16:56:31-04:00July 21, 2023|Geographic & priority populations|

Virtual care technologies during the COVID-19 pandemic changed how healthcare was received among Canadian gay, bisexual and queer men

A CITF-funded study, published in Sociology of Health and Illness, discovered that virtual care (healthcare at home using mainly telephone consultations) not only helps with delivering and receiving medical care but also brings about changes in the ways that people interact and provide care.

Seroprevalence provides an accurate measure of SARS-CoV-2 infection compared to PCR testing

A CITF-funded study, published in the CMAJ Open, found that seroprevalence data is a very useful mechanism to obtain accurate measures of the prevalence of SARS-CoV-2 infection in the population, and when compared to PCR testing which under detects the number of infections was more reflective of the true burden.

2023-04-18T14:37:02-04:00April 15, 2023|Geographic & priority populations|

Pregnant individuals more reticent to get vaccinated in 2021

Despite the fact that pregnant individuals were prioritized for COVID-19 vaccination in late April 2021, a CITF-funded study, published in Vaccine, showed that COVID-19 vaccine coverage with at least one dose among pregnant individuals (71.2%) remained lower than in the general population of reproductive-age females (88%) at the end of 2021.

2023-02-20T15:13:55-05:00February 20, 2023|Geographic & priority populations|
Go to Top